市场调查报告书
商品编码
1561578
2024-2032 年按类型、针长度、治疗方法、购买方式、最终用户和地区分類的笔针市场报告Pen Needles Market Report by Type, Needle Length, Therapy, Mode of Purchase, End User, and Region 2024-2032 |
2023年,全球笔用针头IMARC Group规模达到37亿美元。市场的推动因素包括糖尿病和慢性病盛行率的上升、老年人口的增加、医疗保健领域投资的增加、技术的快速进步、胰岛素自我管理的不断发展以及优惠报销政策的实施。
糖尿病和其他慢性病的盛行率不断增加
全球糖尿病和其他慢性疾病盛行率的上升是推动笔用针头市场成长的主要因素。根据国际糖尿病联盟 (IDF) 的糖尿病图谱,到 2021 年,20 至 79 岁的成年人口中有 10.5% 患有糖尿病,其中一半以上不知道自己的诊断结果。该预测预计,到 2045 年,每 8 名成年人中就有 1 人(即近 7.83 亿人)患有糖尿病,增幅约为 46%。据此,糖尿病管理需要频繁监测和胰岛素注射,这是透过配备笔针的胰岛素笔来完成的。笔式针头因其简单易用而成为需要频繁注射胰岛素的糖尿病患者不可或缺的工具。
不断扩大的老年人口
笔用针头市场预测强调,老年人口的扩大是导致该市场成长的重要因素。由于与年龄相关的生理变化和较高的合併症盛行率,老年人更容易患慢性疾病,包括糖尿病。据世界卫生组织(WHO) 称,到2050 年,全球60 岁以上人口比例预计将增加近一倍,从2015 年的12% 增至22%。产生深远影响。此外,具有易于操作、最小疼痛和安全机制等特点的笔针对于这个年龄层的人是有益的。随着老年人口的持续成长,针对其特定需求的产品需求预计将会增加,从而推动市场的扩张。
医疗保健领域的投资不断增长
多个国家对医疗保健行业的资金投入不断增加,正在加强笔针的市场份额。例如,2022年,欧洲政府在卫生方面的整体支出总计1,2,210亿欧元,占GDP的7.7%。同样,印度的公共医疗保健支出在 2023 财年占 GDP 的 2.1%,在 2022 财年占 GDP 的 2.2%。这种扩张改善了糖尿病等疾病的诊断、监测和管理,从而增加了对笔用针头的需求。此外,具有成本效益的保险范围和报销计划的可用性一直鼓励患者探索使用胰岛素笔和笔针作为治疗选择。例如,2022 年某个时候,美国 92.1% 的人(即 3.040 亿人)拥有健康保险,这也增加了笔用针头的需求。
IMARC Group提供了每个细分市场的主要趋势的分析,以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据类型、针头长度、治疗方法、购买方式和最终用户对市场进行了分类。
标准笔针占据大部分市场份额
该报告根据类型提供了详细的市场细分和分析。这包括标准笔针和安全笔针。根据该报告,标准笔针代表了最大的部分。
根据笔用针头市场前景和分析,由于患者和医疗保健提供者的广泛使用和接受,标准笔用针头细分市场占据了最大份额。这些针头设计适合大多数胰岛素笔,并以其多功能性、易用性以及各种长度和规格的可用性而闻名。此外,标准笔针头因其成本效益和确保与各种胰岛素输送系统相容的广泛选择而成为首选。除此之外,设计和技术的不断改进提高了注射时的舒适度并减少了疼痛,对笔针的市场价值产生了积极影响。
8mm行业占有率第一
报告中还提供了基于针长度的详细市场细分和分析。这包括 4 毫米、5 毫米、6 毫米、8 毫米、10 毫米和 12 毫米。报告显示,8mm占据了最大的市场份额。
根据笔用针头市场报告和趋势,8mm 针头长度部分在市场上占据最大份额,这归因于其平衡的功效和对广大患者的舒适度。此长度被认为是皮下胰岛素输送的最佳长度,确保充分渗透到皮下组织,同时最大限度地降低肌肉注射的风险。此外,8毫米针头因其多功能性而受到医疗保健提供者的广泛推荐,适合成人和儿童。同时,8毫米针头在临床实践中的广泛使用,加上患者的熟悉和接受,正在扩大笔用针头的市场规模。
胰岛素代表领先的市场
该报告根据该疗法提供了详细的市场区隔和分析。这包括胰岛素、GLP-1 和生长激素。根据该报告,胰岛素占了最大的份额。
根据笔用针头市场概况和细分,由于糖尿病盛行率不断上升以及注射胰岛素以进行有效疾病管理的必要性,胰岛素治疗占据了最大份额。与此一致的是,胰岛素治疗需要频繁且精确的注射,因此笔针成为糖尿病患者的必备工具。此外,笔针的便利性、准确性和疼痛的减少提高了患者的依从性和生活质量,这也促进了市场的成长。此外,先进胰岛素笔的开发和产品技术的不断创新正在支撑笔针市场价格趋势。
零售业在市场上表现出明显的主导地位
报告还根据购买方式对市场进行了详细的细分和分析。这包括零售和非零售。报告称,零售业占据最大的市场份额。
根据笔针市场研究报告,零售领域占据了最大的份额,这得益于它为消费者提供的便利性和可及性。零售药局和网路商店为患者提供了一个简单、即时的存取点,因为它们可以提供快速的用品,而无需前往医疗机构。除此之外,广泛的零售通路分销网络确保了产品的广泛供应,满足城乡人口的需求。此外,零售店还提供各种品牌和产品,使患者可以选择最适合其需求和偏好的笔用针头。
医院和诊所主导市场
该报告提供了基于最终用户的详细市场细分和分析。这包括医院和诊所、家庭医疗保健等。报告称,医院和诊所是最大的部分。
医院和诊所构成了最大的部分,这是由于在这些环境中进行的大量医疗程序和慢性病管理所推动的。他们是初级医疗保健提供者,大量糖尿病患者接受诊断、治疗计划和持续管理,因此需要稳定供应用于胰岛素注射和其他注射疗法的笔针。此外,这些医疗机构优先考虑患者的安全和疗效,选择高品质的针头以确保精确、舒适的药物输送。此外,医院和诊所是对患者进行正确使用这些针头教育的第一站,从而促进了市场成长。
欧洲引领市场,占据最大的笔用针头市场份额
该报告还对所有主要区域市场进行了全面分析,其中包括北美(美国和加拿大);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告称,欧洲是笔用针最大的区域市场。
在糖尿病高盛行率、先进的医疗基础设施和政府支持政策的共同推动下,欧洲在笔用针头行业占据了最大的份额。与此一致的是,强大的医疗保健系统提供了广泛的糖尿病管理工具,再加上强有力的报销框架的增加支持,减轻了患者的经济负担,正在推动市场成长。除此之外,人们对糖尿病照护的高度认识,以及积极的公共卫生运动和促进使用这些笔的教育计划,有利于市场的成长。此外,几家领先的医疗设备製造商的存在促进了创新并提高了先进针头技术的可用性,这刺激了笔针头市场的收入。
(请注意,这只是关键参与者的部分列表,报告中提供了完整列表。)
The global pen needles market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.3 Billion by 2032, exhibiting a growth rate (CAGR) of 12.7% during 2024-2032. The market is driven by the rising prevalence of diabetes and chronic diseases, expanding geriatric population, increasing investment in the healthcare sector, rapid technological advancements, growing self-administration of insulin, and the imposition of favorable reimbursement policies.
Increasing Prevalence of Diabetes and Other Chronic Diseases
The rising prevalence of diabetes and other chronic diseases across the globe is a major factor driving the pen needles market growth. According to the International Diabetes Federation's (IDF) Diabetes Atlas, 10.5% of the adult population aged 20 to 79 had diabetes in 2021, with over half unaware of the diagnosis. By 2045, this forecast predicts that one in every eight adults, or nearly 783 million, will have diabetes, which is an approximately 46% rise. In line with this, diabetes management necessitates frequent monitoring and insulin administration, which is accomplished with insulin pens equipped with pen needles. Pen needles are an indispensable tool for diabetes patients who require frequent insulin injections due to their ease and user-friendliness.
Expanding Geriatric Population
The pen needles market forecast highlights that the expanding geriatric population is a significant factor that is resulting in the growth of this market. Geriatric adults are more susceptible to chronic diseases, including diabetes, due to age-related physiological changes and a higher prevalence of comorbidities. According to the World Health Organization (WHO), the proportion of the world's population over 60 years is projected to nearly double from 12% in 2015 to 22% by 2050. This demographic shift has profound implications for healthcare systems and the demand for medical devices. Additionally, pen needles that are designed with features like easy handling, minimal pain, and safety mechanisms are beneficial for this age group. As the geriatric population continues to grow, the demand for products that are tailored to their specific needs is expected to increase, driving the expansion of the market.
Growing Investment in the Healthcare Sector
The increasing funding in the healthcare industry by several countries is strengthening the pen needle market share. For example, in 2022, Europe's overall government spending on health totaled €1221 billion, or 7.7% of GDP. Similarly, India's public healthcare spending accounted for 2.1% of GDP in FY23 and 2.2% in FY22. This expansion has been allowing for improved diagnosis, monitoring, and management of illnesses such as diabetes, which drives up the demand for pen needles. Furthermore, the availability of cost-effective insurance coverage and reimbursement schemes have been encouraging patients to explore the use of insulin pens and pen needles as a treatment option. For instance, 92.1 percent of people, or 304.0 million in the U.S., had health insurance at some point during 2022, which also increased the pen needles demand.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, needle length, therapy, mode of purchase, and end user.
Standard pen needles accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes standard pen needles and safety pen needles. According to the report, standard pen needles represented the largest segment.
As per the pen needles market outlook and analysis, the standard pen needles segment represented the largest share, driven by their widespread usage and acceptance among patients and healthcare providers. These needles are designed to fit most insulin pens and are known for their versatility, ease of use, and availability in various lengths and gauges. Moreover, standard pen needles are preferred due to their cost-effectiveness and the broad range of options that ensure compatibility with various insulin delivery systems. Besides this, the continuous improvements in design and technology, which enhance comfort and reduce pain during injections, are positively impacting the pen needle market value.
8mm holds the largest share of the industry
A detailed breakup and analysis of the market based on the needle length have also been provided in the report. This includes 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. According to the report, 8mm accounted for the largest market share.
Based on the pen needles market report and trends, the 8mm needle length segment holds the largest share in the market, attributed to its balanced efficacy and comfort for a wide range of patients. This length is considered optimal for subcutaneous insulin delivery, ensuring adequate penetration to the subcutaneous tissue while minimizing the risk of intramuscular injection. Moreover, the 8mm needles are widely recommended by healthcare providers due to their versatility, making them suitable for adults and children. Along with this, the extensive use of 8mm needles in clinical practice, coupled with patient familiarity and acceptance, is enhancing the pen needles market size.
Insulin represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the therapy. This includes insulin, GLP-1, and growth hormones. According to the report, insulin represented the largest segment.
According to the pen needles market overview and segmentation, insulin therapy constituted the largest share, driven by the growing prevalence of diabetes and the necessity of insulin administration for effective disease management. In line with this, insulin therapy requires frequent and precise injections, making pen needles an essential tool for diabetic patients. Moreover, the rising convenience, accuracy, and reduced pain associated with pen needles that enhance patient compliance and quality of life are contributing to the market growth. Additionally, the development of advanced insulin pens and continuous innovations in product technology are supporting the pen needle market price trends.
Retail exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on the mode of purchase have also been provided in the report. This includes retail and non-retail. According to the report, retail accounted for the largest market share.
As per the pen needles market research report, the retail segment represented the largest share, driven by the convenience and accessibility it offers to consumers. Retail pharmacies and online stores provide an easy and immediate access point for patients as they offer quick supplies without the need for a medical facility visit. Besides this, the broad distribution networks of retail channels ensure widespread availability, catering to urban and rural populations. Additionally, retail outlets offer a variety of brands and products, allowing patients to choose pen needles that best meet their needs and preferences.
Hospitals and clinics dominate the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, home healthcare, and others. According to the report, hospitals and clinics represented the largest segment.
Hospitals and clinics constituted the largest segment, driven by the high volume of medical procedures and chronic disease management performed in these settings. They are primary healthcare providers where a significant number of diabetes patients receive their diagnosis, treatment plans, and ongoing management, necessitating a steady supply of pen needles for insulin administration and other injectable therapies. Moreover, these healthcare facilities prioritize patient safety and efficacy, opting for high-quality needles to ensure precise and comfortable medication delivery. Additionally, hospitals and clinics serve as the first point of education for patients on the correct use of these needles, boosting the market growth.
Europe leads the market, accounting for the largest pen needles market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe represents the largest regional market for pen needles.
Europe holds the largest segment in the pen needles industry, driven by a combination of high diabetes prevalence, advanced healthcare infrastructure, and supportive government policies. In line with this, the robust healthcare systems that provide extensive access to diabetes management tools, coupled with increased support from strong reimbursement frameworks that reduce the financial burden on patients, are boosting the market growth. Along with this, the high awareness of diabetes care, with proactive public health campaigns and educational programs that promote the use of these pens, is favoring the market growth. Additionally, the presence of several leading medical device manufacturers that foster innovation and boost the availability of advanced needle technologies is stimulating the pen needle market revenue.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)